# Sana Biotechnology, Inc. (SANA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Sana Biotechnology, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/SANA/mda/fy2025/): filed 2026-03-03; accession 0001193125-26-088215 (https://www.sec.gov/Archives/edgar/data/1770121/000119312526088215/sana-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/SANA/mda/fy2024/): filed 2025-03-17; accession 0000950170-25-040254 (https://www.sec.gov/Archives/edgar/data/1770121/000095017025040254/sana-20241231.htm)
- [FY 2023 MD&A](/company/SANA/mda/fy2023/): filed 2024-02-29; accession 0000950170-24-023119 (https://www.sec.gov/Archives/edgar/data/1770121/000095017024023119/sana-20231231.htm)
- [FY 2022 MD&A](/company/SANA/mda/fy2022/): filed 2023-03-16; accession 0001564590-23-003798 (https://www.sec.gov/Archives/edgar/data/1770121/000156459023003798/sana-10k_20221231.htm)
- [FY 2021 MD&A](/company/SANA/mda/fy2021/): filed 2022-03-16; accession 0001564590-22-010539 (https://www.sec.gov/Archives/edgar/data/1770121/000156459022010539/sana-10k_20211231.htm)

Back to /company/SANA/